BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12200787)

  • 1. Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report.
    Jain AK; Venkataramanan R; Fridell JA; Gadomski M; Shaw LM; Ragni M; Korecka M; Fung J
    Liver Transpl; 2002 Sep; 8(9):838-40. PubMed ID: 12200787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients.
    Jain AK; Venkataramanan R; Shapiro R; Scantlebury VP; Potdar S; Bonham CA; Ragni M; Fung JJ
    Liver Transpl; 2002 Sep; 8(9):841-5. PubMed ID: 12200788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients.
    Jain AB; Venkataramanan R; Eghtesad B; Marcos A; Ragni M; Shapiro R; Rafail AB; Fung JJ
    Liver Transpl; 2003 Sep; 9(9):954-60. PubMed ID: 12942457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
    Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P
    Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in patients with HIV infection.
    Fung J; Eghtesad B; Patel-Tom K; DeVera M; Chapman H; Ragni M
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S39-53. PubMed ID: 15382219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
    Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
    Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation.
    Guaraldi G; Cocchi S; Codeluppi M; Di Benedetto F; Bonora S; Pecorari M; Gennari W; Cautero N; Pinna AD; Gerunda GE; Esposito R
    Transplant Proc; 2005; 37(6):2609-10. PubMed ID: 16182761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus and liver transplantation: our point of view.
    Di Benedetto F; Di Sandro S; De Ruvo N; Berretta M; Montalti R; Guerrini GP; Ballarin R; De Blasiis MG; Spaggiari M; Smerieri N; Iemmolo RM; Guaraldi G; Gerunda GE
    Transplant Proc; 2008; 40(6):1965-71. PubMed ID: 18675102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
    Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review.
    Robertson SM; Scarsi KK; Postelnick MJ; Lynch P
    Pharmacotherapy; 2005 Aug; 25(8):1068-72. PubMed ID: 16207097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
    Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
    Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal transplantation in HIV-infected patients in Spain].
    Mazuecos A; Pascual J; Gómez E; Sola E; Cofán F; López F; Puig-Hooper CE; Baltar JM; González-Molina M; Oppenheimer F; Marcén R; Rivero M
    Nefrologia; 2006; 26(1):113-20. PubMed ID: 16649432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nelfinavir in children: influencing factors and dose implications.
    Bergshoeff AS; Fraaij PL; van Rossum AM; Wolfs TF; Geelen SP; de Groot R; Burger DM
    Antivir Ther; 2003 Jun; 8(3):215-22. PubMed ID: 12924538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus for rescue of steroid and anti-thymocyte globulin-resistant recurrent acute rejection after liver transplantation: report of one case.
    Demirağ A; Kalayci M; Ekci B; Gülçelik T; Gökçe O
    Transplant Proc; 2009; 41(1):435-6. PubMed ID: 19249574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.
    Duval X; Peytavin G; Albert I; Bénoliel S; Ecobichon JL; Brun-Vézinet F; Mentré F; Leport C; Vildé JL
    HIV Med; 2004 Jul; 5(4):307-13. PubMed ID: 15236622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease.
    Neff GW; Bonham A; Tzakis AG; Ragni M; Jayaweera D; Schiff ER; Shakil O; Fung JJ
    Liver Transpl; 2003 Mar; 9(3):239-47. PubMed ID: 12619020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.